Evidence map›Paper›PMID 35040345›Full record

SynthesisThe Journal of international medical research2022

Risk factors for methicillin-resistant

Xuefei Hu, Keao Hu, Yanling Liu, Lingbing Zeng, Niya Hu, Xiaowen Chen, Wei Zhang

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The global epidemiology of MRSA.JAC-antimicrobial resistance · 2026
    Review
  4. Article
  5. Article
  6. NasopharyngealAccess microbiology · 2023
    Article
  7. Review
  8. Nasal carriage of meticillin-resistantInfection prevention in practice · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xuefei HuClinical Laboratory of the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Keao HuDepartment of Urology, The First Clinical College of Nanchang University Medical College, Nanchang, Jiangxi Province, China.
Yanling LiuClinical Laboratory of the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Lingbing ZengClinical Laboratory of the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Niya HuClinical Laboratory of the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Xiaowen ChenClinical Laboratory of the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Wei ZhangDepartment of Respiration, 117970First Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.ORCID https://orcid.org/0000-0002-3716-1831
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the potential factors affecting methicillin-resistant

methodsA systematic search of publications listed in electronic from inception up to August 2020 was conducted. A random-effects model was used to calculate odds ratio (OR) with 95% confidence interval (CI).

resultsA total of 31 studies reporting 1410 MRSA events in 17 427 patients with HIV infection were included. Previous hospitalization (OR 1.80; 95% CI 1.37, 2.36), previous antibiotic therapy (OR 2.69; 95% CI 2.09, 3.45), CD4+ count (OR 1.79; 95% CI 1.41, 2.28), Centers for Disease Control and Prevention classification of stage C (OR 2.66; 95% CI 1.80, 3.93), skin lesions (OR 2.02; 95% CI 1.15, 3.55), intravenous device use (OR 2.61; 95% CI 1.59, 4.29) and an MRSA colonization history (OR 6.30; 95% CI 2.50, 15.90) were significantly associated with an increased risk of MRSA colonization and infection. Antiretroviral therapy (OR 0.71; 95% CI 0.50, 0.99) and current antibiotic use (OR 0.13; 95% CI 0.05, 0.32) were significantly associated with a reduced risk of MRSA colonization and infection.

conclusionMRSA colonization and infection in HIV-infected patients is associated with a number of risk factors.

Indexed as

HIV InfectionsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsCD4 Lymphocyte CountHumansRisk Factorscomprehensive risk stratificationhuman immunodeficiency virusMethicillin-resistant Staphylococcus aureusskin and soft-tissue infections

Identifiers

PMID35040345
PMCPMC8777361
OpenAlexW4206479572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.